quipazine has been researched along with ly 53857 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Audia, JE; Baez, M; Cohen, ML; Kursar, JD; Lucaites, VL; Nelson, DL; Nissen, JS; Schenck, KW; Wainscott, DB | 1 |
| Jacobs, M; McRee, C; Meyer, DC | 1 |
| Alper, RH | 1 |
| Alper, RH; Snider, JM | 1 |
| Booth, NH; Hatch, RC; Jernigan, AD; Lipham, LB; Robbins, JD | 1 |
| Cohen, ML; Fuller, RW; Garbrecht, WL; Kurz, KD; Marzoni, GP; Mason, NR | 1 |
| Ahlborn, EN; Bailey, SP; Davis, JM | 2 |
8 other study(ies) available for quipazine and ly 53857
| Article | Year |
|---|---|
Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
Topics: Animals; Binding Sites; Cell Line; Cloning, Molecular; Gastric Fundus; Inositol 1,4,5-Trisphosphate; Male; Muscle Contraction; Muscle, Smooth; Radioligand Assay; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Temperature | 1993 |
Role of 5-hydroxytryptamine receptors on luteinizing-hormone-releasing hormone release in the ovariectomized, estradiol-treated rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Ergolines; Estradiol; Female; Gonadotropin-Releasing Hormone; Hypothalamus, Middle; Ketanserin; Ovariectomy; Pindolol; Preoptic Area; Quipazine; Radioimmunoassay; Rats; Receptors, Serotonin; Serotonin Antagonists; Suprachiasmatic Nucleus; Tetrahydronaphthalenes | 1992 |
Evidence for central and peripheral serotonergic control of corticosterone secretion in the conscious rat.
Topics: Amidines; Amphetamines; Animals; Corticosterone; Dexamethasone; Ergolines; Male; Quipazine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists | 1990 |
Activation of serotonin2 (5-HT2) receptors by quipazine increases arterial pressure and renin secretion in conscious rats.
Topics: Animals; Blood Pressure; Ergolines; Heart Rate; Male; Quinolines; Quipazine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Renin | 1987 |
Effect of clonidine, quipazine, and LY 53857 on the prolactin-suppressant action of bromocriptine in rats.
Topics: Animals; Bromocriptine; Clonidine; Drug Interactions; Ergolines; Male; Pituitary Gland, Anterior; Prolactin; Quinolines; Quipazine; Rats; Rats, Inbred Strains; Serotonin Antagonists | 1986 |
Pharmacological activity of the isomers of LY53857, potent and selective 5-HT2 receptor antagonists.
Topics: Animals; Blood Pressure; Cerebral Cortex; Corticosterone; Decerebrate State; Ergolines; Isomerism; Male; Mathematics; Quipazine; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Receptors, Serotonin; Spiperone; Time Factors | 1985 |
Neuroendocrine and substrate responses to altered brain 5-HT activity during prolonged exercise to fatigue.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Blood Glucose; Brain; Dopamine; Ergolines; Fatigue; Fatty Acids, Nonesterified; Glycogen; Male; Physical Exertion; Quipazine; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists | 1993 |
Serotonergic agonists and antagonists affect endurance performance in the rat.
Topics: Amidines; Animals; Dose-Response Relationship, Drug; Ergolines; Female; Injections, Intraperitoneal; Male; Physical Endurance; Placebos; Quipazine; Rats; Rats, Wistar; Running; Serotonin Antagonists; Time Factors | 1993 |